[HTML][HTML] Controlling timing and location in vaccines

DJ Irvine, A Aung, M Silva - Advanced Drug Delivery Reviews, 2020 - Elsevier
Vaccines are one of the most powerful technologies supporting public health. The adaptive
immune response induced by immunization arises following appropriate activation and …

Advances in saponin-based adjuvants

HX Sun, Y Xie, YP Ye - Vaccine, 2009 - Elsevier
Saponins are natural glycosides of steroid or triterpene which exhibited many different
biological and pharmacological activities. Notably, saponins can also activate the …

Identification of QS-21 as an inflammasome-activating molecular component of saponin adjuvants

R Marty-Roix, GI Vladimer, K Pouliot, D Weng… - Journal of Biological …, 2016 - ASBMB
Many immunostimulants act as vaccine adjuvants via activation of the innate immune
system, although in many cases it is unclear which specific molecules contribute to the …

The role of antibodies in HIV vaccines

JR Mascola, DC Montefiori - Annual review of immunology, 2009 - annualreviews.org
Licensed vaccines against viral diseases generate antibodies that neutralize the infecting
virus and protect against infection or disease. Similarly, an effective vaccine against HIV-1 …

Saponins from Quillaja saponaria and Quillaja brasiliensis: Particular Chemical Characteristics and Biological Activities

JD Fleck, AH Betti, FP Da Silva, EA Troian, C Olivaro… - Molecules, 2019 - mdpi.com
Quillaja saponaria Molina represents the main source of saponins for industrial applications.
Q. saponaria triterpenoids have been studied for more than four decades and their …

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

J Fan, X Liang, MS Horton, HC Perry, MP Citron… - Vaccine, 2004 - Elsevier
A universal influenza virus vaccine that does not require frequent updates and/or annual
immunizations will offer significant advantages over current seasonal flu vaccines. The …

Direct probing of germinal center responses reveals immunological features and bottlenecks for neutralizing antibody responses to HIV Env trimer

C Havenar-Daughton, DG Carnathan, AT de la Peña… - Cell reports, 2016 - cell.com
Generating tier 2 HIV-neutralizing antibody (nAb) responses by immunization remains a
challenging problem, and the immunological barriers to induction of such responses with …

Adjuvant effects of saponins on animal immune responses

ZI Rajput, S Hu, C Xiao, AG Arijo - Journal of zhejiang university science B, 2007 - Springer
Vaccines require optimal adjuvants including immunopotentiator and delivery systems to
offer long term protection from infectious diseases in animals and man. Initially it was …

Recent developments in adjuvants for vaccines against infectious diseases

DT O'Hagan, ML MacKichan, M Singh - Biomolecular engineering, 2001 - Elsevier
New generation vaccines, particularly those based on recombinant proteins and DNA, are
likely to be less reactogenic than traditional vaccines, but are also less immunogenic …

[HTML][HTML] Induction of immunity to human immunodeficiency virus type-1 by vaccination

MJ McElrath, BF Haynes - Immunity, 2010 - cell.com
Recent findings have brought optimism that development of a successful human
immunodeficiency virus type-1 (HIV-1) vaccine lies within reach. Studies of early events in …